Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease.

Abstract

The aim of the present study was to identify the distribution of the second melatonin receptor (MT2) in the human hippocampus of elderly controls and Alzheimer's disease (AD) patients. This is the first report of immunohistochemical MT2 localization in the human hippocampus both in control and AD cases. The specificity of the MT2 antibody was ascertained by fluorescence microscopy using the anti-MT2 antibody in HEK 293 cells expressing recombinant MT2, in immunoblot experiments on membranes from MT2 expressing cells, and, finally, by immunoprecipitation experiments of the native MT2. MT2 immunoreactivity was studied in the hippocampus of 16 elderly control and 16 AD cases. In controls, MT2 was localized in pyramidal neurons of the hippocampal subfields CA1-4 and in some granular neurons of the stratum granulosum. The overall intensity of the MT2 staining was distinctly decreased in AD cases. The results indicate that MT2 may be involved in mediating the effects of melatonin in the human hippocampus, and this mechanism may be heavily impaired in AD.

• Authors: Egemen Savaskan, Mohammed A Ayoub, Rivka Ravid, Debora Angeloni, Franco Fraschini, Fides Meier, Anne Eckert, Franz Müller-Spahn, Ralf Jockers
• Journal: Journal of pineal research (J Pineal Res) Vol. 38 Issue 1 Pg. 10-6 (Jan 2005) ISSN: 0742-3098 [Print] England
• PMID: 15617532 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Receptor, Melatonin, MT2
• Recombinant Proteins

Topics

• Aged
• Alzheimer Disease (metabolism)
• Antibody Specificity
• Cell Line
• Electrophoresis, Polyacrylamide Gel
• Hippocampus (metabolism)
• Humans
• Immunohistochemistry
• Microscopy, Fluorescence
• Receptor, Melatonin, MT2 (immunology, metabolism)
• Recombinant Proteins (immunology, metabolism)